DIATHEVA

About DIATHEVA

DIATHEVA is an Italian biotech CDMO founded in 2002 with the aim to bring research into industrial products by cooperating with firms, public and private research institutions. Thanks to the strong internal know-how and long experience in the biotech arena, DIATHEVA represents the best partner for: - Research, development and GMP production of biologics (antibodies, recombinant proteins, enzymes...) 
- Research, development and manufacturing of human, veterinary and environmental assays based on both immuno- enzymatic and molecular techniques (ELISA and PCR).

Read more Show less
Certifications
  • CE
    CE
  • GMP
    GMP
  • ISO
    ISO
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Italy
  • On CPHI since:
    2019
  • Certificates:
    3
  • Employees:
    1 - 24
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Manufacturer/Innovator
Primary activities
API Producer
Biopharmaceutical
Contract Manufacturer
Contact info
  • Website
  • Via Sant'Anna 131/13, 61030, Cartoceto, Italy
Show contact info Hide contact info
Meet us at

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
View Exhibitor Profile

DIATHEVA Resources (2)

  • Custom Antibody Services

    Brochure Custom Antibody Services

    Diatheva can provide customized services for polyclonal and monoclonal antibodies for your specific application.


    A full service is available for all types of antibodies production, including antigen design, immunogen preparation, antibody development, antibody purification and characterization.


    Leverage our expertise in antibody production.

  • Contract Development and GMP Manufacturing Services

    Brochure Contract Development and GMP Manufacturing Services

    We are well positioned to efficiently and expertly support your entire project at all stages of biopharmaceutical development, from cell line generation through process development. 

    In our state-of-the art GMP production facility authorized by EMA we produce and release biological Active Pharmaceutical Ingredients (APIs) for preclinical and Phase I/II clinical trials.